logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
E

Expert Opinion on Drug Metabolism & Toxicology

IF3.4
论文数68
被引数
期刊论文 68
发表时间
delete
Safety and drug-drug interaction profiles of oral selective estrogen receptor degraders: implications for clinical practice口服选择性雌激素受体降解剂的安全性和药物相互作用特征：对临床实践的意义
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-10-23
delete0
PREAI
deleteTaha Koray Sahin; Deniz Can Guven; Sercan Aksoy
delete分享
delete收藏
Obstetric pharmacotranscriptomics产科药理转录组学
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-10-22
delete0
PREAI
deleteAhizechukwu C. Eke
delete分享
delete收藏
Interpreting variability in atypical antipsychotic levels: a practical review for TDM解读非典型抗精神病药物水平变化：一份治疗药物监测（TDM）的实用综述
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-10-20
delete0
deleteOAAI
deleteZuzana Hajšelová; Danica Michaličková; Karolína Škutová; Jaroslava Červeňová; Jana Hroudová
delete分享
delete收藏
Managing urinary tract infections in pregnancy: teratogenic risks, molecular mechanisms, and antibiotic safety孕期泌尿道感染的管理：致畸风险、分子机制和抗生素安全性
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-10-04
delete0
PREAI
deleteBiswajeet Acharya; Durga Prasad Mishra; Pallishree Bhukta; Amulyaratna Behera
delete分享
delete收藏
How close are we to AI-enabled digital biomarkers in clinical toxicology?我们离临床毒理学中的AI赋能数字生物标志物还有多远？
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-10-03
delete0
deleteOAAI
deleteFederico Goodsaid
delete分享
delete收藏
Computational approaches to predicting xenobiotic metabolism by the human gut microbiota预测人类肠道微生物对 xenobiotic 代谢的计算方法
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-09-29
delete0
PREAI
deleteAnton S. Kolodnitsky; Alexey A. Lagunin; Vladimir V. Poroikov
delete分享
delete收藏
Methods of predicting clinically significant DRUG-DRUG interactions beyond validated interaction checkers预测临床显著药物相互作用的方法：超越已验证的相互作用检查器
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-09-24
delete0
PREAI
deleteSlobodan M. Jankovic; Milijana T. Jovanović; Gorana Nedin Ranković
delete分享
delete收藏
Population pharmacokinetic/pharmacodynamic modeling of NH600001 reveals age-related differences in sedation response and supports individualized dosing in elderly patientsNH600001的群体药代动力学/药效动力学模型揭示镇静反应的年龄相关性差异，并支持老年患者的个体化给药
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-09-17
delete0
PREAI
deleteYa-Jie Cao; Yun Kuang; Qi Gao; Kun-Hong Deng; Qi Pei; Ya-Xin Liu; Guo-Ping Yang
delete分享
delete收藏
Pharmacokinetics of novel drugs for the treatment of diabetic nephropathy新型药物治疗糖尿病肾病的药代动力学
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-09-10
delete0
PREAI
deleteTaraneh Mousavi; Fadia T. Shaya; Kashif M. Munir; Stephen N. Davis
delete分享
delete收藏
Preventing drug interactions with antiretrovirals in the aging HIV population: focusing on population pharmacokinetic modeling预防抗逆转录病毒药物在老龄化HIV人群中的药物相互作用：聚焦于群体药代动力学建模
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-09-06
delete0
PREAI
deleteBailey Thayer; Onyema Ogbuagu
delete分享
delete收藏
Pharmacologic and clinical considerations of phosphodiesterase type 5 inhibitors and β-adrenergic receptor type 3 agonists for lower urinary tract symptoms and benign prostatic hyperplasia磷酸二酯酶5抑制剂和β-肾上腺素能受体3激动剂在治疗下尿路症状与良性前列腺增生中的药理学和临床考量
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-08-28
delete0
PREAI
deleteEviatar Fields; Dean Elterman; Naeem Bhojani; Jennifer Polo; Bilal Chughtai
delete分享
delete收藏
Multitask learning in predictive toxicology: methods, benchmarks, and applications预测毒理学中的多任务学习：方法、基准和应用
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-08-27
delete0
PREAI
deleteHuixiao Hong; Jie Liu; Wenjing Guo; Tucker A. Patterson
delete分享
delete收藏
Sex and gender differences in the effects of immunosuppressive drugs in patients with kidney transplantation肾移植患者中免疫抑制药物效应的性别差异
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-08-13
delete0
PREAI
deleteClaudia Lo Re; Elisa Longhitano; Guido Gembillo; Domenico Santoro
delete分享
delete收藏
Artificial intelligence in dermatologic pharmacokinetics: quantitative modeling, clinical translation, and optimization of precision therapeutics人工智能在皮肤药代动力学中的应用：定量建模、临床转化和精准治疗的优化
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-08-11
delete0
PREAI
deleteMohamad Goldust
delete分享
delete收藏
GLP-1RA pharmacokinetics and clinical effects: focus on cardiac, vascular, and glomerular structures胰高血糖素样肽-1受体激动剂（GLP-1RA）的药代动力学和临床效果：聚焦于心脏、血管和肾小球结构
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-08-06
delete0
PREAI
deleteIvano Barnaba; Francesco Massari; Marco Matteo Ciccone; Pasquale Caldarola; Cosimo Campanella; Gabriella Ricci; Pietro Scicchitano
delete分享
delete收藏
Inavolisib: a second-generation PI3Kα inhibitor in HR+/HER2-negative breast cancerInavolisib：一种用于HR+/HER2阴性乳腺癌的第二代PI3Kα抑制剂
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-07-28
delete0
PREAI
deleteElaria Abdy; Jean-Pierre Betancourt; Supratik Kar
delete分享
delete收藏
Drug-drug interactions in patients living with HIV and major depressionHIV合并重度抑郁症患者中的药物相互作用
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-07-15
delete0
PREAI
deleteIvy Antwi; Theodore J. Cory
delete分享
delete收藏
An update on beta-lactam–beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens关于β-内酰胺–β-内酰胺酶抑制剂组合治疗碳青霉烯耐药革兰阴性病原体的最新进展
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-30
delete0
deleteOAAI
deleteIlias Karaiskos; Aikaterini Gkoufa; Evdoxia Kyriazopoulou; Eleni Polyzou; Vasiliki Rapti; Konstantinos Ioannidis; Evangelia Chrysanthopoulou; Zoe Athanassa; Karolina Akinosoglou; Garyphalia Poulakou; null
delete分享
delete收藏
The use of natural language processing in predictive toxicology自然语言处理在预测毒理学中的应用
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-29
delete0
deleteOAAI
deleteThomas Hartung
delete分享
delete收藏
Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach联合利福平和克拉霉素对伊塞卡福韦-tezacaftor-维卡福韦药代动力学影响的生理药代动力学（PBPK）模型研究
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-23
delete0
PREAI
deleteMadeline Sanders; Eunjin Hong; Manya Jain; Paul Beringer
delete分享
delete收藏